StockData
Vor Biopharma Inc. logo

Vor Biopharma Inc. (VOR) stock

VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 5/30
$17.83−0.35 (-1.93%)

Close on Nov 18, 2026Market cap $1.10BP/E –Yield –

Vor Biopharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Vor Biopharma

Vor Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Vor Biopharma figures

See a number that looks wrong?